TRIPs框架下药品专利权和公共健康的平衡  

Striking a Balance between Patent Rights and Public Health: The TRIPS Attempt

作　　者：杜碧玉[1] 

机构地区：[1]广东外语外贸大学,广东广州510420

出　　处：《广东广播电视大学学报》2009年第2期48-54,共7页Journal of Guangdong Radio & Television University

摘　　要：昂贵的药物使发展中国家的病人无法获得必需的药品,发展中国家从而面临严重的公共健康危机。人权主义者为此指责药品专利保护制度,认为获得药品的治疗是基本人权,但药品制造商却认为专利制度是促进新药研发的必要激励制度。世界贸易组织的《与贸易有关的知识产权协定》试图在两者中取得平衡。本论文就TRIPs如何在专利和公共健康中保持平衡进行分析,结合其最新的发展,指出其存在的不足,并提出相关的建议。Patients in developing countries cannot afford expensive medicines and thus causing serious public health crisis.Human right activists blame the strong patent system,insisting that access to medicines is a basic human right,while pharmaceutical manufacturers maintain that strong patent protection is essential for providing incentives for development of new drugs.The Agreement on Trade-related Aspects of Intellectual Property Rights(TRIPs) attempts to strike a balance between these two streams.This paper inv...

关 键 词：公共健康 药品专利 平衡 

分 类 号：D997.1[政治法律—国际法学]